• Mohammad A Al-Ghamdi, Rajaa M Al-Raddadi, Iman K Ramadan, Ahmad A Mirza, Hanan A Alsaab, Hani F Alobaidi, and Mohammed Y Bin Hayd.
• From the Department of Preventive Medicine (AL-Ghamdi), Health Surveillance Center, Ministry of Health, Al Medina Al Munawarah; from the Department of Community Medicine (Al-Raddadi, Ramadan, Bin Hayd), Faculty of Medicine; from the Department of Otolaryngology-Head and Neck Surgery (Mirza), Faculty of Medicine in Rabigh, King Abdulaziz University; from the Department of Medical Records (Alsaab), King Abdullah Medical Complex, Ministry of Health, Jeddah; from the Department of Preventive Dentistry (Alobaidi), Ministry of Health, Taif, Kingdom of Saudi Arabia; from the Department of Community Medicine (Ramadan), Faculty of Medicine, Al-Azhar University, Cairo, Egypt; and from the Department of Otolaryngology-Head and Neck Surgery (Mirza), Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
• Saudi Med J. 2022 Aug 1; 43 (8): 915926915-926.

ObjectivesTo assess the survival of COVID-19 patients in Saudi Arabia and to investigate possible mortality predictors.MethodsThis is a retrospective cohort study involving 248 patients with severe acute respiratory syndrome coronavirus-2 who were admitted to the primary COVID-19 referral hospital in Jeddah between March and June of 2020. Socio-demographic characteristics, comorbidities, laboratory investigations, management protocols, complications, treatment options, and mortality data were extracted from electronic medical records. The time analysis began at the first signs of illness thorough discharge or death.ResultsOur study showed that in-hospital complications including heart failure followed by acute renal failure had the largest effect size on mortality (p<0.001). Elderly patients and those with comorbid asthma had a higher risk of death. Non-survivors presented more commonly with shortness of breath and fever than survivors. High D-Dimer level was a marginally significant indicator of mortality in the studied population (p=0.05). We did not find a significant benefit in relation to any treatment option.ConclusionAge, asthma, some in-hospital complications are important survival indicators in hospitalized COVID-19 patients. The controllable co-factors should be monitored and managed by healthcare workers to reduce mortality rates in those hospitalized with COVID-19.Copyright: © Saudi Medical Journal.

16 keywords...

hide…